Details for New Drug Application (NDA): 081319
✉ Email this page to a colleague
NDA 081319 describes PYRAZINAMIDE, which is a drug marketed by Hikma, Macleods Pharms Ltd, and Novitium Pharma, and is included in three NDAs. It is available from eight suppliers. Additional details are available on the PYRAZINAMIDE profile page.
The generic ingredient in PYRAZINAMIDE is pyrazinamide. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the pyrazinamide profile page.
The generic ingredient in PYRAZINAMIDE is pyrazinamide. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the pyrazinamide profile page.
Summary for 081319
| Tradename: | PYRAZINAMIDE |
| Applicant: | Hikma |
| Ingredient: | pyrazinamide |
| Patents: | 0 |
Suppliers and Packaging for NDA: 081319
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PYRAZINAMIDE | pyrazinamide | TABLET;ORAL | 081319 | ANDA | Hikma Pharmaceuticals USA Inc | 0054-0812 | 0054-0812-21 | 60 TABLET in 1 CONTAINER (0054-0812-21) |
| PYRAZINAMIDE | pyrazinamide | TABLET;ORAL | 081319 | ANDA | Hikma Pharmaceuticals USA Inc | 0054-0812 | 0054-0812-22 | 90 TABLET in 1 CONTAINER (0054-0812-22) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Jun 30, 1992 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
